Pacira BioSciences, Inc.
PCRX
$25.23
$0.783.19%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -103.73M | -99.56M | -90.73M | 63.59M | 70.47M |
Total Depreciation and Amortization | 81.53M | 78.79M | 76.03M | 74.21M | 74.40M |
Total Amortization of Deferred Charges | 3.38M | 3.22M | 3.06M | 2.91M | 2.84M |
Total Other Non-Cash Items | 219.97M | 225.46M | 225.32M | 73.77M | 58.86M |
Change in Net Operating Assets | -25.41M | -18.52M | -9.83M | -20.12M | -21.95M |
Cash from Operations | 175.75M | 189.39M | 203.84M | 194.36M | 184.62M |
Capital Expenditure | -16.35M | -10.64M | -10.32M | -9.62M | -11.43M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -16.70M | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -60.33M | -72.64M | -64.22M | -17.10M | 7.26M |
Cash from Investing | -93.38M | -83.28M | -74.53M | -26.71M | -4.17M |
Total Debt Issued | 287.50M | 287.50M | 287.50M | 287.50M | 0.00 |
Total Debt Repaid | -210.89M | -210.89M | -210.89M | -235.88M | -36.25M |
Issuance of Common Stock | 2.30M | 2.30M | 2.50M | 2.53M | 4.42M |
Repurchase of Common Stock | -25.67M | -25.49M | -25.52M | -25.49M | -110.00K |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -36.06M | -36.06M | -36.06M | -36.06M | 0.00 |
Cash from Financing | 17.19M | 17.36M | 17.54M | -7.40M | -31.94M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 99.56M | 123.48M | 146.85M | 160.24M | 148.51M |